Princeton Portfolio Strategies Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-1,220
Closed -$204K 152
2019
Q2
$204K Sell
1,220
-3,724
-75% -$516K 0.05% 143
2019
Q1
$724K Sell
4,944
-1,075
-18% -$156K 0.19% 100
2018
Q4
$804K Sell
6,019
-3,840
-39% -$629K 0.25% 90
2018
Q3
$1.88M Buy
9,859
+453
+5% +$83.2K 0.49% 60
2018
Q2
$1.57M Sell
9,406
-175
-2% -$28.1K 0.45% 63
2018
Q1
$1.61M Buy
+9,581
New +$1.61M 0.46% 67

Other funds holding AGN

Princeton Portfolio Strategies Group's AGN Position: Q3 2019 in Review

Princeton Portfolio Strategies Group sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 1,220 shares — an estimated $204K sold.

Princeton Portfolio Strategies Group first reported a position in AGN in Q1 2018 and held it in 6 quarters. The position peaked at $1.88M in Q3 2018. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Princeton Portfolio Strategies Group reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Princeton Portfolio Strategies Group sold 1,220 Allergan plc shares in Q3 2019, an estimated $204K.
  • Princeton Portfolio Strategies Group first reported a position in Allergan plc in Q1 2018 and held it in 6 quarters.
  • Princeton Portfolio Strategies Group's Allergan plc position peaked at $1.88M in Q3 2018.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Princeton Portfolio Strategies Group's 13F filing for Q3 2019, filed 12 Nov 2019.